B cell subsets in pristane-induced autoimmunity

Current Topics in Microbiology and Immunology

Volumn 252, Issue , 2000, Pages 201-207

  Richards, H B ^a   Reap, E A ^a   Shaw, M ^a   Satoh, M ^a   Yoshida, H ^a   Reeves, W H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PRISTANE;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; LUPUS ERYTHEMATOSUS; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PLASMACYTOMA; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033757520     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-57284-5_21     Document Type: Conference Paper

References (27)

1. Origin of murine B cell lineages
2. Inhibition of murine B-1 lymphocytes by interleukin-12
3. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD 19 signal transduction molecule
4. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
5. The role of complement and complement receptors in induction and regulation of immunity
6. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies
7. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire
8. Mapping of a gene for the increased susceptibility of B-1 cells to Mort cell formation in murine autoimmune disease
9. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on routine chromosome 4 leads to B cell hyperactivity
10. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in 1pr mice
11. Plasmacytomagenesis in mice: Model of neoplastic development dependent upon chromosomal translocations
12. BALB/c. CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis
13. Antinuclear antibody production and immune complex glomerulonephritis in BALB/c mice treated with pristane
14. Pathogenesis of autoantibody production and glomerulonephritis in pristane-treated mice: An inducible model of SLE
15. Interleukin 6 is essential for in vivo development of B lineage neoplasms
16. IL-6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-induced lupus
17. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane
18. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus
19. Induction of B cell autoimmunity by pristane
20. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice
21. DNA-binding antibodies from viable motheaten mutant mice. Implications for B cell tolerance
22. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression
23. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: Beta 2-microglobulin-dependent and independent forms
24. NK cell receptors
25. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice
26. The 'Ly-1 B' cell subpopulation in normal immunodefective, and autoimmune mice
27. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice